Evidence map›Paper›PMID 36520178›Full record

ArticleEuropean radiology2023

Brain deposition of gadobutrol in children-a cross-sectional and longitudinal MRI T1 mapping study.

Daniel Gräfe, Stefan-Horia Simion, Maciej Rosolowski, Andreas Merkenschlager, Jens Frahm, Dirk Voit, Franz Wolfgang Hirsch

Abstract read
In one paragraph

Article in European radiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Gadolinium Contrast Agent Deposition in Children.Journal of magnetic resonance imaging : JMRI · 2025
    Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Daniel GräfeDepartment of Pediatric Radiology, University Hospital, Leipzig University, Liebigstraße 20a, 04103, Leipzig, Germany. daniel.graefe@medizin.uni-leipzig.de.ORCID http://orcid.org/0000-0002-7680-0990
Stefan-Horia SimionDepartment of Radiology, Municipal Hospital, Dessau, Germany.
Maciej RosolowskiInstitute for Medical Informatics, Statistics and Epidemiology, Leipzig University, Leipzig, Germany.
Andreas MerkenschlagerDepartment of Neuropediatrics, University Hospital, Leipzig, Germany.
Jens FrahmBiomedizinische NMR, Max-Planck-Institut für Multidisziplinäre Naturwissenschaften, Göttingen, Germany.
Dirk VoitBiomedizinische NMR, Max-Planck-Institut für Multidisziplinäre Naturwissenschaften, Göttingen, Germany.
Franz Wolfgang HirschDepartment of Pediatric Radiology, University Hospital, Leipzig University, Liebigstraße 20a, 04103, Leipzig, Germany.

Funding

European Society for Paediatric Radiology Guy Sebag Grant
6 · The paper itself

Abstract

objectivesDepositions of linear gadolinium-based MRI contrast agents are readily visible in T1-weighted MRIs of certain brain regions in both adults and children. Macrocyclic contrast agents such as gadobutrol have so far escaped detection by qualitative MRI in children. This study aimed to assess whether there is evidence for deposition of gadobutrol in children using quantitative T1 mapping.

methodsThis retrospective study included patients, naive to other gadolinium-based contrast agents than gadobutrol, who had received gadobutrol as part of a clinically indicated MRI. For each patient, T1 relaxation times at 3 T were measured using single-shot T1 mapping at two time points. In each of six brain regions, age-adjusted T1 relaxation times were correlated with a number of previous gadobutrol administrations. To combine interindividual, cross-sectional effects with intraindividual, longitudinal effects, both linear mixed model and generalized additive mixed model were applied.

resultsOne hundred four examinations of 52 children (age median 11.4, IQR 6.3-15, 26 female) with a median of 7 doses of gadobutrol in the history of their neurological or neurooncological disease were included. After correction for age and indeterminate disease-related effects to T1 time, a negative correlation of T1 time with the number of gadobutrol doses administered was observed in both mixed models in the putamen (beta - 1.65, p = .03) and globus pallidus (beta - 1.98, p = .012)

conclusionsThe results indicate that in children, gadobutrol is deposited in the globus pallidus and putamen. KEY POINTS: • Previous gadobutrol administration correlates with reduced T1 relaxation times in the globus pallidus and putamen in children. • This decreased T1 might be caused by gadobutrol retention within these gray-matter nuclei.

Indexed as

Contrast MediaOrganometallic CompoundsAdultBrainCerebellar NucleiChildCross-Sectional StudiesFemaleGadoliniumHumansMagnetic Resonance ImagingRetrospective StudiesContrast MediagadobutrolGadoliniumOrganometallic CompoundsBrainChildrenGadoliniumMagnetic resonance imaging

Identifiers

PMID36520178
PMCPMC10289941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.